Metastatic prostate cancer with elevated serum levels of CEA and CA19-9

Guang Dar Juang, Yi-Sheng Huang, Yuan Hung Wang

Research output: Contribution to journalArticlepeer-review

5 Citations (Scopus)


Prostate-specific antigen (PSA) is well known as a specific tumor marker for prostate cancer, but carcinoembryonic antigen (CEA)- and carbohydrate antigen 19-9 (CA19-9)-elevating adenocarcinomas originating in the prostate gland are rare. We report a case of metastatic adenocarcinoma of the prostate gland with a high serum level of CEA and CA19-9 in a 78-year-old man in whom prostate cancer (T3N1M1) had been diagnosed 2 years ago and who was treated with androgen deprivation therapy. He visited the emergency department because of a loss of appetite and abdominal pain. The serum CEA and CA19-9 levels were increased to 218.9. ng/mL (normal,

Original languageEnglish
Pages (from-to)28-30
Number of pages3
JournalUrological Science
Issue number1
Publication statusPublished - 2014


  • Carbohydrate antigen 19-9 (CA19-9)
  • Carcinoembryonic antigen (CEA)
  • Metastatic prostate cancer
  • Tumor marker

ASJC Scopus subject areas

  • Urology


Dive into the research topics of 'Metastatic prostate cancer with elevated serum levels of CEA and CA19-9'. Together they form a unique fingerprint.

Cite this